Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03079687
Title Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Recruitment Approved for marketing
Gender
Phase Expanded access
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site Newport Beach California 92663 United States Details
Research Site Roseville California 95661 United States Details
Research Site Gainesville Florida 32608 United States Details
Research Site Scarborough Maine 04074 United States Details
Research Site Baltimore Maryland 21201 United States Details
Research Site Rochester Minnesota 55905 United States Details
Research Site Columbia Missouri 65212 United States Details
Research Site Albuquerque New Mexico 87106 United States Details
Research Site Durham North Carolina 27710 United States Details
Research Site Winston-Salem North Carolina 27157-1023 United States Details
Research Site Cleveland Ohio 44195 United States Details
Research Site Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field